Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Altered pharmacokinetics in the elderly.

G J Yuen1

  • 1School of Pharmacy, University of Maryland, Baltimore.

Clinics in Geriatric Medicine
|May 1, 1990
PubMed
Summary
This summary is machine-generated.

Aging alters drug pharmacokinetics, potentially requiring dose adjustments in older adults. While kidney function tests aid dosing, liver function tests are less reliable for predicting drug metabolism changes.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A comparison of the steady-state pharmacokinetics and safety of abacavir, lamivudine, and zidovudine taken as a triple combination tablet and as abacavir plus a lamivudine-zidovudine double combination tablet by HIV-1-infected adults.

Pharmacotherapy·2001
Same author

Short-term measures of relative efficacy predict longer-term reductions in human immunodeficiency virus type 1 RNA levels following nelfinavir monotherapy.

Antimicrobial agents and chemotherapy·2001
Same author

Abacavir/lamivudine/zidovudine as a combined formulation tablet: bioequivalence compared with each component administered concurrently and the effect of food on absorption.

Journal of clinical pharmacology·2001
Same author

Population pharmacokinetics of lamivudine in adult human immunodeficiency virus-infected patients enrolled in two phase III clinical trials.

Antimicrobial agents and chemotherapy·1999
Same author

Clinical pharmacokinetics of lamivudine.

Clinical pharmacokinetics·1999
Same author

Serum and cerebrospinal fluid pharmacokinetics of intravenous and oral lamivudine in human immunodeficiency virus-infected children.

Antimicrobial agents and chemotherapy·1998
Same journal

Cardiovascular Prevention in Older Adults: From Estimation to Treatment.

Clinics in geriatric medicine·2026
Same journal

Preventive Cardiology for the Clinically Complex Older Adult.

Clinics in geriatric medicine·2026
Same journal

A Preventive Neurology Perspective on Promoting Brain Health and Preventing Cardiovascular Disease.

Clinics in geriatric medicine·2026
Same journal

Secondary Prevention in Older Adults: Putting It All Together.

Clinics in geriatric medicine·2026
Same journal

Primary Prevention in Older Adults: Putting It All Together.

Clinics in geriatric medicine·2026
Same journal

Managing Bleeding Risk in Older Adults: Antithrombotics and Anticoagulants.

Clinics in geriatric medicine·2026
See all related articles

Area of Science:

  • Gerontology
  • Clinical Pharmacology
  • Drug Metabolism

Background:

  • Physiologic changes during aging can significantly impact how the body processes drugs (pharmacokinetics).
  • Altered drug pharmacokinetics in the elderly may lead to either toxic drug effects or insufficient therapeutic outcomes.
  • Understanding these age-related pharmacokinetic changes is crucial for safe and effective medication management in older populations.

Observation:

  • Renal (kidney) function tests can be quantitatively utilized to personalize drug dosages for individual elderly patients.
  • Hepatic (liver) function tests show a weaker correlation with the actual changes in hepatic drug metabolism observed in aging individuals.
  • This variability highlights the complexity of predicting drug behavior solely based on standard liver function tests in the elderly.

Related Experiment Videos

Findings:

  • Age-related physiological shifts directly influence drug absorption, distribution, metabolism, and excretion.
  • Kidney function provides a more reliable quantitative marker for adjusting drug doses in the elderly compared to liver function.
  • Hepatic drug metabolism in older adults is not consistently reflected by standard liver function tests.

Implications:

  • Individualized drug dosage adjustments are essential for the elderly to prevent adverse drug reactions and ensure treatment efficacy.
  • Clinicians should consider utilizing renal function assessments for prospective drug dosing in geriatric patients.
  • Further research may be needed to develop better methods for assessing hepatic drug metabolism in the aging population.